Skip to main content

MedPath Trial Home

Organizations News Research

Data Sources:ClinicalTrials.govEU CTRFDAEMANMPATGAHealth CanadaWHO ICTRP

MedPath Trial Home

Search trials. Track pipelines. Understand approvals. With AI-powered intelligence for clinical research.

Product

Clinical Trials
Drug Intelligence
Global Approvals
AI Research
Pricing

Resources

FAQ
Search

Company

News
About
Contact

Legal

Privacy Policy
Terms of Service

Disclaimer: This website provides information retrieval and data analysis services. The content does not constitute medical advice. Eligibility assessments are for reference only and should not replace consultation with qualified healthcare professionals. Data is sourced from public registries and regulatory agencies; MedPath does not guarantee completeness or accuracy. Always verify information with primary sources.

© 2026 MedPath Trial. All rights reserved.

We value your privacy

We use cookies to analyze site traffic and improve your experience. See our Privacy Policy.

COLLOMACK SALICYLIC ACID SOLUTION 10% - HSA Drug Approval Details

Approvals/HSA/COLLOMACK SALICYLIC ACID SOLUTION 10%

Approved

THERAPEUTIC

COLLOMACK SALICYLIC ACID SOLUTION 10%

PAUL W. BEYERS GMBH (GERMANY)🇸🇬 Health Sciences Authority

Approval Date: Nov 12, 2009
Approval ID: 086e5d225c2122cb
Company: PAUL W. BEYERS GMBH (GERMANY)
Type: Therapeutic

Approval Details

Approval Id: 086e5d225c2122cb
Drug Name: COLLOMACK SALICYLIC ACID SOLUTION 10%
Product Name: COLLOMACK SALICYLIC ACID SOLUTION 10%
Approval Number: SIN13728P
Approval Date: 2009-11-12
Registrant: RX PHARMA PTE. LTD.
Licence Holder: RX PHARMA PTE. LTD.
Drug Type: Therapeutic
Forensic Classification: GENERAL SALE LIST
Dosage Form: SOLUTION
Route Of Administration: TOPICAL
Atc Code: D01AE12
Atc Item Name: salicylic acid
Pharma Manufacturer Name: RX PHARMA PTE. LTD.
Company Detail Path: /organization/rx-pharma-pte-ltd

Active Ingredients

Salicylic acid

100mg

SALICYLIC ACID

100 MG

Approved

Quick Info

Agency

HSA

Country

🇸🇬

Approval Date

Nov 12, 2009

Approval ID

086e5d225c2122cb

Type

Therapeutic

Back to HSA Approvals